Intrahepatic mutagenesis assay: a sensitive method for detecting N-nitrosomorpholine and in vivo nitrosation of morpholine.
An intrahepatic host-mediated mutagenicity assay capable of detecting low levels of N-nitrosomorpholine (NMOR) is described. The indicator organism was Salmonella typhimurium TA1530 which had been injected intravenously 10 min prior to the administration of the test compound. The bacteria were subsequently recovered from the liver and scored for revertants by standard methods. The lower limit of detectibility of this system for intubated NMOR was 0.2 microgram/g body weight. This assay was then used to study the formation of NMOR in vivo from morpholine and nitrite which had been sequentially gavaged to mice. Under acidic conditions (pH 3.4) 12--19% of the administered morpholine was converted to NMOR in the presence of excess nitrite. This nitrosation, and the subsequent uptake and activation of the NMOR, took place so rapidly that most of the total mutagenic response was complete within 15 min. This response was inhibited by prior intubation of ascorbic acid, a known inhibitor of nitrosation, and enhanced by sodium thiocyanate, a nitrosation catalyst.
D000818:Animals; D001711:Biotransformation; D005260:Female; D005821:Genetic Techniques; D008099:Liver / Q000382:microbiology*; D051379:Mice; D009025:Morpholines / Q000378:metabolism* / Q000494:pharmacology; D009153:Mutagens; D009154:Mutation / Q000187:drug effects; D009602:Nitrosamines / Q000378:metabolism* / Q000494:pharmacology; D012486:Salmonella typhimurium / Q000235:genetics*
D009025:Morpholines; D009153:Mutagens; D009602:Nitrosamines; C002741:N-nitrosomorpholine